Risk for nonarteritic anterior ischemic optic neuropathy was more than doubled among patients initiating semaglutide vs SGLT2is.
Tirzepatide use lowered risk for diabetic retinopathy incidence and worsening events compared with lifestyle intervention alone.
Paris II and Momah/Lindor biochemical response criteria predict improved transplant-free survival and serve as potential ...
Åsa H. Everhov, M.D., from the Karolinska Institutet in Stockholm, and colleagues evaluated rectal cancer risk in patients ...
Greater weight loss was linked to greater willingness to continue semaglutide use, even when accompanied by gastrointestinal side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results